Skip to main content
logo
Viva Biotech Holdings (HKG:1873)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.240
+0.040 (3.33%)
Jul 10, 2026, 10:49 AM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Contract Development Manufacture Organisation (CDMO) and Commercialisation Services
894.11M1.18B1.31B1.48B1.36B
Contract Development Manufacture Organisation (CDMO) and Commercialisation Services Growth
-24.19%-10.30%-11.44%8.87%428.22%
Drug Discovery Services
854.72M821.31M866.76M895.06M740.47M
Drug Discovery Services Growth
4.07%-5.24%-3.16%20.88%68.75%
Elimination
-28.69M-32.09M-56.54M--
Viva Bioinnovator
9.31M18.09M30.61M--
Viva Bioinnovator Growth
-48.56%-40.90%---
Total
1.73B1.99B2.16B2.38B2.10B
Total Growth
-12.95%-7.84%-9.42%13.10%201.90%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States of America (USA)
830.80M795.83M812.79M915.82M646.52M
United States of America (USA) Growth
4.39%-2.09%-11.25%41.65%62.88%
Europe
461.28M623.34M589.56M508.47M590.23M
Europe Growth
-26.00%5.73%15.95%-13.85%363.00%
Chinese Mainland
259.65M267.23M323.67M382.38M376.74M
Chinese Mainland Growth
-2.84%-17.44%-15.35%1.50%224.08%
Other Asia countries and regions out of Chinese Mainland
92.27M193.53M291.39M392.80M330.08M
Other Asia countries and regions out of Chinese Mainland Growth
-52.32%-33.59%-25.82%19.00%845.69%
Africa
17.82M45.27M45.03M64.55M74.18M
Africa Growth
-60.64%0.53%-30.24%-12.98%422.92%
Others
67.63M61.47M93.14M115.62M86.34M
Others Growth
10.03%-34.00%-19.44%33.91%1096.60%
Total
1.73B1.99B2.16B2.38B2.10B
Total Growth
-12.95%-7.84%-9.42%13.10%201.90%